
NovoCure Limited NVCR
Quarterly report 2025-Q2
added 07-24-2025
NovoCure Limited DSO Ratio 2011-2026 | NVCR
Annual DSO Ratio NovoCure Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.8 | 52.8 | 61 | 64.9 | 197 | 89.2 | 69.6 | 71.7 | 62.5 | 105 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 197 | 40.8 | 81.5 |
Quarterly DSO Ratio NovoCure Limited
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.1 | 46.7 | - | 38.8 | 39.4 | 41.6 | - | 48.8 | 52.8 | 60.1 | - | 30.5 | 32.7 | 64.5 | 64.3 | 63 | 62.5 | 64.1 | 61.3 | 17.9 | 17.9 | 14.4 | 54.1 | 15.3 | 15.3 | 12.4 | 47.8 | 13.4 | 13.4 | 57.9 | 50.3 | 53.8 | 70.3 | 47 | 19.1 | 6.98 | 6.98 | 3.49 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 70.3 | 3.49 | 38.8 |
DSO Ratio of other stocks in the Health care industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
37 | - | -2.32 % | $ 107 B | ||
|
Cigna Corporation
CI
|
31 | $ 292.97 | 1.75 % | $ 80.2 B | ||
|
CVS Health Corporation
CVS
|
34.6 | $ 76.61 | 1.3 % | $ 97.1 B | ||
|
Triple-S Management Corporation
GTS
|
48.2 | - | 0.28 % | $ 847 M | ||
|
Magellan Health, Inc.
MGLN
|
59.3 | - | -0.19 % | $ 2.49 B | ||
|
Humana
HUM
|
7.34 | $ 175.92 | -2.94 % | $ 21.2 B | ||
|
Centene Corporation
CNC
|
30.5 | $ 40.34 | - | $ 21 B | ||
|
Molina Healthcare
MOH
|
27.4 | $ 121.43 | -3.13 % | $ 6.41 B | ||
|
UnitedHealth Group Inc.
UNH
|
19.9 | - | 2.09 % | $ 257 B |